Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:WTW
NasdaqGS:WTWInsurance

Assessing Willis Towers Watson’s Valuation After Stock Pullback Mixed Earnings And RiskAgility FM Upgrade

Willis Towers Watson (WTW) has moved into focus after a sharp pullback from its late 2025 share price peak, mixed quarterly earnings, sector jitters around AI distribution, and a fresh upgrade to its RiskAgility FM platform. See our latest analysis for Willis Towers Watson. Recent volatility has been sharp, with a 7 day share price return of 13.55% and a 30 day share price return of 13.57% pulling Willis Towers Watson back to US$282.98, even though the 3 year total shareholder return of...
ASX:PDN
ASX:PDNOil and Gas

Does Stronger Liquidity And Rising Uranium Sales Change The Bull Case For Paladin Energy (ASX:PDN)?

Paladin Energy reported its December 2025 half-year results, with quarterly sales rising to US$102.38 million and net income to US$6.27 million, while recent equity raisings of A$300 million plus a A$100 million share purchase plan and a syndicated debt restructure bolstered its liquidity to fund Langer Heinrich and Patterson Lake South. An interesting takeaway is that despite six‑month net income of just US$0.872 million, Paladin has materially strengthened its balance sheet to support...
BME:AMS
BME:AMSHospitality

Assessing Amadeus IT Group’s Valuation As The Singapore Airshow Presentation Draws Market Attention

Singapore Airshow presentation puts Amadeus IT Group (BME:AMS) in focus Amadeus IT Group (BME:AMS) is drawing fresh attention ahead of its February 5, 2026 appearance at the Singapore Airshow, where regional airlines lead Sarah Samuel is scheduled to present. See our latest analysis for Amadeus IT Group. The upcoming Singapore Airshow appearance comes at a weaker share price backdrop, with Amadeus IT Group’s 30 day share price return of 22.44% and 1 year total shareholder return of 30.44%...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Protagonist Therapeutics (PTGX) Valuation Check After Strong Multi Year Shareholder Returns

Protagonist Therapeutics (PTGX) is back on investor watchlists after recent trading moves, with its latest close at US$81.93 highlighting how the market is currently pricing its late stage pipeline and revenue profile. See our latest analysis for Protagonist Therapeutics. Recent trading has been choppy, with a 1.9% single day share price decline and a modest 7 day share price gain. However, the 1 year total shareholder return of 111.8% and the very large 3 year total shareholder return of...
NYSE:TRN
NYSE:TRNMachinery

A Look At Trinity Industries (TRN) Valuation After Its Recent Share Price Surge

Recent performance and business snapshot Trinity Industries (TRN) has caught investor attention after a recent share price move, with the stock showing strong gains over the past month and past 3 months. This has prompted a closer look at the railcar specialist. The company reports annual revenue of US$2,175.1 million and net income of US$103.3 million, reflecting its role in providing railcar products and services across North America through leasing, maintenance, and manufacturing...
NYSE:CAH
NYSE:CAHHealthcare

Cardinal Health (CAH) Is Down 5.3% After Raising Profit Outlook On Specialty Strength And Capital Returns – Has The Bull Case Changed?

In early February 2026, Cardinal Health reported past second-quarter 2025 results showing sales of US$65,627 million and net income of US$467 million, alongside higher earnings per share and confirmation of its ongoing capital return program through share repurchases and a quarterly dividend of US$0.5107 per share. The company’s stronger pharmaceutical and specialty segment performance, coupled with raised profit guidance and continued investment in higher-margin specialty and services...
HLSE:SITOWS
HLSE:SITOWSConstruction

Sitowise Group Oyj (HLSE:SITOWS) Q4 EPS Loss Of €1.11 Tests Profitability Narratives

Sitowise Group Oyj (HLSE:SITOWS) has wrapped up FY 2025 with Q4 revenue of €50.2 million and a basic EPS loss of €1.11, alongside a Q4 net loss of €39.9 million. Over recent quarters the company has seen revenue move between €40.4 million and €50.2 million, while quarterly EPS has ranged from a loss of €0.01 to a much deeper loss of €1.11. This is likely to lead investors to focus squarely on how margins are holding up through this period. See our full analysis for Sitowise Group Oyj. With...
ASX:CBA
ASX:CBABanks

Why Commonwealth Bank of Australia (ASX:CBA) Is Up 12.2% After Lifting Earnings and Its Fully Franked Dividend

Commonwealth Bank of Australia has reported higher half‑year earnings to 31 December 2025, with net income rising to A$5,367 million and basic earnings per share from continuing operations lifting to A$3.237, and it has declared a fully franked interim dividend of A$2.35 per share payable on 30 March 2026. By combining record cash earnings with an increased fully franked dividend and continued investment in technology and AI, the bank is signalling confidence in its core franchise strength...
NYSE:ADC
NYSE:ADCRetail REITs

Is Agree Realty (ADC) Pricing Look Attractive After Recent 1-Year Share Price Gain?

If you are looking at Agree Realty and wondering whether the current share price reflects its true worth, you are not alone. The stock last closed at US$76.58, with returns of 0.6% over 7 days, 7.2% over 30 days, 6.2% year to date and 11.2% over 1 year, while the 5 year return stands at 47.5%. Recent attention on Agree Realty has focused on its position in the listed real estate sector and on how investors are treating income focused names relative to other asset classes. This context helps...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

Evaluating Palo Alto Networks (PANW) After Recent Share Price Weakness

If you are wondering whether Palo Alto Networks is priced attractively or not, this article walks through the key numbers behind the stock rather than just the headlines. The share price recently closed at US$162.81, with returns of 2.2% over 7 days, a 14.7% decline over 30 days, a 9.2% decline year to date, an 18.6% decline over 1 year, but gains of 92.4% over 3 years and 146.1% over 5 years. Recent news around Palo Alto Networks has focused on its role as a major cyber security provider...
TSE:8987
TSE:8987Office REITs

A Look At Japan Excellent (TSE:8987) Valuation After New ¥100,000 Million Bond Shelf Registration

Japan Excellent (TSE:8987) has filed a shelf registration for up to ¥100,000 million in investment corporation bonds, giving it a multi-year funding option for property acquisitions, upkeep, refinancing, and day-to-day operations. See our latest analysis for Japan Excellent. That funding option lands at a time when the share price is around ¥151,000, with a modest 90 day share price return of 1.68% and a much stronger 1 year total shareholder return of 27.43%. This points to momentum that has...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Critical Metals Tanbreez Assays Highlight Resource Scale But Share Volatility

Critical Metals (NasdaqGM:CRML) reported final assay results from its 2025 drilling program at the Tanbreez Rare Earths Project in Greenland. The results highlight substantial rare earth mineralization across the project area. Management indicated that the assays reinforce the large scale resource potential and support future development plans. The company plans to use these data to guide further drilling and advance key project milestones in 2026. Critical Metals, trading at $9.83, has...
NYSE:WST
NYSE:WSTLife Sciences

West Pharmaceutical Services Margins Slip To 16.3% Raising Questions Around Bullish Growth Narratives

West Pharmaceutical Services (WST) just posted its FY 2025 third quarter scorecard, with revenue of US$804.6 million and basic EPS of US$1.94 setting the tone for the latest update. The company has seen revenue move from US$702.1 million in Q2 2024 to US$804.6 million in Q3 2025, while basic EPS has ranged from US$1.52 in Q2 2024 to US$1.94 in the latest quarter. This gives investors a clearer view of how the top line and per share earnings have tracked through the last six reported periods...
NYSE:ADM
NYSE:ADMFood

Akralos Venture Puts ADM Animal Nutrition And Valuation In Focus

ADM (NYSE:ADM) and Alltech have launched Akralos, a North American animal nutrition joint venture, which is now fully operational. The venture combines ADM’s feed operations with Alltech’s brands and expertise in animal nutrition. Akralos is positioned as one of the largest animal feed and nutrition platforms in North America. For you as an investor looking at ADM (NYSE:ADM), Akralos ties directly into the company’s existing footprint in agricultural processing and animal feed. Animal...
ENXTPA:RI
ENXTPA:RIBeverage

Assessing Pernod Ricard (ENXTPA:RI) Valuation After Recent Share Price Rebound And Margin Expansion Hopes

Recent share performance and context Pernod Ricard (ENXTPA:RI) has attracted fresh attention after a solid recent share price move, with the stock up about 2.5% over the past day and roughly 13% over the past month. That short term strength comes alongside a past 3 months return of about 4.4%, while the 1 year total return sits near an 8.9% decline and the 3 year total return around a 50.8% decline. Over a 5 year span, the total return is about a 39.2% decline. This contrasts with a year to...
BME:CIE
BME:CIEAuto Components

CIE Automotive India's Solar Foray And Technical Shift Might Change The Case For Investing In CIE Automotive (BME:CIE)

CIE Automotive India recently held its Q4 and full-year CY25 results conference call, alongside confirming a ₹2.63 crore investment by its subsidiary into a solar energy venture, signalling a move into renewable power. At the same time, the stock’s technical profile has shifted with an upgraded rating and mixed but improving indicators that traders are watching closely. We’ll now examine how CIE Automotive India’s push into solar energy could influence the broader investment narrative for...
NYSE:TRU
NYSE:TRUProfessional Services

TransUnion (TRU) Margin Jump To 9.5% Challenges Earnings Skeptics

TransUnion (TRU) just posted its latest FY 2025 numbers with Q3 revenue of US$1.2b, basic EPS of US$0.50 and net income excluding extra items of US$96.6m, set against trailing 12 month revenue of US$4.4b and EPS of US$2.16. These figures reflect an 87.5% year over year earnings jump and a move in net margin from 5.5% to 9.5%. The company has seen quarterly revenue range from US$1.0b in Q4 2024 to US$1.2b in Q3 2025. Over the same period, quarterly EPS moved from US$0.34 to US$0.76 and then...
NYSE:BMI
NYSE:BMIElectronic

Is Badger Meter’s (BMI) Insider Buying Amid Margin Pressures Quietly Reframing Its Competitive Narrative?

In early February 2026, Badger Meter reported a fourth-quarter earnings miss while Executive Vice President Robert Wrocklage acquired 1,650 company shares amid ongoing cost and competitive pressures. This combination of weaker-than-expected results, margin headwinds and insider buying has sharpened investor focus on the company’s resilience and long-term positioning in smart water infrastructure. With insider buying occurring alongside margin pressures from tariffs and input costs, we’ll now...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Assessing Lam Research (LRCX) Valuation After Earnings Beat And New AI Collaboration With CEA Leti

Lam Research (LRCX) is back in focus after reporting quarterly results ahead of analyst expectations and unveiling a multi year collaboration with CEA Leti, aimed at next generation semiconductor devices for AI and high performance computing. See our latest analysis for Lam Research. The recent earnings beat and CEA Leti partnership come on top of strong price momentum, with a 90 day share price return of 56% and a very large 1 year total shareholder return of 180.2%. This suggests investors...
ENXTPA:RMS
ENXTPA:RMSLuxury

Is Hermès (ENXTPA:RMS) Pricing Reflect Its Luxury Strength After A 22% One‑Year Slide?

If you are wondering whether Hermès International Société en commandite par actions at around €2,174 a share still makes sense on a valuation basis, this article walks through what the current price might be implying. The stock has had a mixed run recently, with a 6.1% gain over the last 7 days, a 2.9% decline over the last 30 days, a 3.3% gain year to date, but a 22.0% decline over the past year, alongside longer term returns of 28.5% over 3 years and 142.0% over 5 years. Recent news...
NYSE:MTN
NYSE:MTNHospitality

Assessing Vail Resorts (MTN) Valuation After Recent Share Price Weakness

What Vail Resorts Stock’s Recent Performance Signals With no single headline event setting the tone, Vail Resorts (MTN) has drawn attention as investors weigh its recent share performance and current fundamentals against its established position in mountain resorts and destination travel. See our latest analysis for Vail Resorts. At a share price of US$136.93, Vail Resorts has seen short term share price pressure, with a 30 day share price return of 3.30% decline and a 12 month total...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

Agios Pharmaceuticals Q3 Loss Of US$103.4m Reinforces Bearish Profitability Narratives

Agios Pharmaceuticals (AGIO) just posted its FY 2025 third quarter numbers, with revenue of US$12.9 million, basic EPS of a US$1.78 loss, and a net income loss of US$103.4 million. The trailing twelve month figures show revenue of US$44.8 million and a net loss of US$401.3 million. The company’s quarterly revenue moved from US$8.6 million in Q2 2024 to US$12.9 million in Q3 2025, while basic EPS shifted from US$16.65 in Q3 2024, driven by a one-off gain, to consistent losses across recent...
TSX:CVG
TSX:CVGCapital Markets

Clairvest Group (TSX:CVG) Quarterly Loss And Margin Compression Challenge High Quality Narrative

Clairvest Group (TSX:CVG) has turned in a mixed Q3 2026 scorecard, with Q2 2026 revenue of C$80.2 million and a net loss of C$76.8 million, translating to basic EPS of C$5.43, following Q1 2026 revenue of C$48.9 million and net income of C$21.3 million, or EPS of C$1.51. Over the past year, the company has seen total revenue range from C$38.9 million in Q1 2025 up to C$54.5 million in Q2 2025, while EPS moved between C$1.63 and C$2.70 across those earlier quarters, setting up a sharp contrast...